Nascent Pharma Holdings Inc (NASC)

[sleekscape]

WHY I LIKE CANB

As the only publicly traded company in America producing and selling a full lineup of Pure CBD Oil products, as well as growing and processing hemp for CBD Isolate, CANB is best positioned to deliver a windfall to its investors in 2020 due to the FDA/Congress permitting Pure CBD in dietary supplements to sell nationally

Mile High Labs and Medterra are two of the biggest CBD Isolate and Pure CBD product companies in America and both are wildly successful, but neither one is publicly traded, so where else can an investor gain exposure to CBD Isolate and Pure CBD products besides CANB?

Being the only CBD Oil stock in America utilizing the formulation of CBD most likely to be permitted to sell nationally by the FDA/Congress is certainly the most obvious advantage that CANB has over the rest of the sector


CANB IS THE ONLY PURE CBD OIL STOCK IN AMERICA:

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=153549640


The FDA’s Take — Why Pure CBD Oil will be the ONLY formulation permitted to sell nationally:

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=153549653


Congress’ Take — Why Full Spectrum CBD Oil Will Remain Illegal Under Current CBD Legalization Bill:

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=153549689


But there are several other advantages that CANB possesses, and the following favorable factors are acting synergistically with CANB’s Pure CBD formulation to give it the greatest % gain potential from current prices in the CBD Oil sector:


1. Most rapid annual revenue growth in the sector

500% revenue growth year-over-year

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=151962562


2. The depth and expertise of the corporate and medical advisory boards

8 MDs, 4 attorneys, 1 orthopedic surgeon and a Senator

https://canbiola.com/management-team/


3. Processor of raw hemp into CBD Isolate (as opposed to Full Spectrum CBD)

That is a unique advantage because CBD Isolate Processing is a huge market, there’s a tremendous lack of processors, and as has already been stated, Pure CBD is likely to be the only formulation to receive FDA approval for national sales

CANB is partnering with Mile High Labs for processing hemp — https://www.milehighlabs.com/


Canbiola Becomes Vertically Integrated with its Joint Venture with NY SHI and Shi Farms

https://www.globenewswire.com/news-release/2019/07/22/1885849/0/en/Canbiola-Becomes-Vertically-Integrated-with-its-Joint-Venture-with-NY-SHI-and-Shi-Farms.html


4. Complete vertical integration from seed to sale

CANB is also a grower of hemp as well, so they have achieved complete vertical integration and full control over the entire supply chain from seed to sale, thereby maximizing profit margins

CANB is partnering with Shi Farms for growing hemp

https://www.shifarms.com/


CANB Growing & Processing Hemp In 4 States — CO, NY, TX, TN

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=152847539


CANB Processing Hemp With Mile High Labs As Partner — Processing is biggest growth area in Hemp/CBD industry in 2020:

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=153362683


Hemp Processing Pics & Vids:

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=153362807


5. Medical Sales

CANB sells to both the retail and medical markets, but they specialize in the sales of CBD Oil products to the medical & healthcare community, which is a far less crowded market than retail


6. 2019 Accomplishments and Growth Plans For 2020:

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=153336437


7. CANB Moving into CBD Foods and Beverages

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=153594436


8. Potential to uplist to Nasdaq

Canbiola, Inc. (the “Company”) submitted an application to be listed on The Nasdaq Capital Market® on June 4, 2019. The Company intends to diligently pursue its application in order to have its securities listed on the Nasdaq Stock Market.

With an independent board of directors and the shareholder equity criteria now met, CANB now has the potential to uplist to the Nasdaq in 2020


Sleek